Exelixis reported $114.98M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US USD 78.11M 11.79M
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Akebia Therapeutics AKBA:US USD 30.92M 1.89M
Amgen AMGN:US USD 1.29B 40M
AstraZeneca AZN:LN USD 3.35B 280M
Bayer BAYN:GR EUR 4.08B 393M
Biomarin Pharmaceutical BMRN:US USD 216.82M 19.98M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Bristol Myers Squibb BMY:US USD 1.93B 147M
Cytokinetics CYTK:US USD 48.22M 5.51M
Eisai 4523:JP JPY 88.08B 4.22B
Eli Lilly And LLY:US USD 1.61B 10.9M
Esperion Therapeutics ESPR:US USD 24.95M 4.65M
Exelixis EXEL:US USD 114.98M 7.78M
Genmab GEN:DC DKK 670M 37M
Glaxosmithkline GSK:US GBP 1.97B 13M
Immunogen IMGN:US USD 33.62M 9.83M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
Macrogenics MGNX:US USD 15.35M 1.69M
Merk MRK:US USD 2.47B 13M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Moderna Inc MRNA:US USD 278M 67M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Neurocrine Biosciences NBIX:US USD 186.3M 3.5M
Novartis NOVN:VX USD 3.4B 185M
Pfizer PFE:US USD 3.54B 345M
Puma Biotechnology PBYI:US USD 23.96M 3.38M
Seattle Genetics SGEN:US USD 210.38M 9.88M
Takeda 4502:JP JPY 248.73B 17.25B
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Xencor XNCR:US USD 12.37M 1.28M
YTE INCY:US USD 266.46M 13.18M